First Time Loading...

Bellerophon Therapeutics Inc
NASDAQ:BLPH

Watchlist Manager
Bellerophon Therapeutics Inc Logo
Bellerophon Therapeutics Inc
NASDAQ:BLPH
Watchlist
Price: 0.0567 USD 0.71% Market Closed
Updated: May 17, 2024

Balance Sheet

Balance Sheet Decomposition
Bellerophon Therapeutics Inc

Current Assets 5m
Cash & Short-Term Investments 4.4m
Other Current Assets 597k
Current Liabilities 1.3m
Accounts Payable 612k
Accrued Liabilities 644k

Balance Sheet
Bellerophon Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
0
17
6
14
29
17
10
48
25
7
Cash Equivalents
0
17
6
14
29
17
10
48
25
7
Short-Term Investments
0
0
18
6
3
0
0
0
0
0
Other Current Assets
2
11
5
6
4
1
1
1
1
1
Total Current Assets
2
28
29
27
36
17
10
48
25
8
PP&E Net
2
2
2
1
1
1
2
2
1
0
PP&E Gross
2
2
2
0
0
1
2
2
1
0
Accumulated Depreciation
1
1
2
0
0
2
2
2
2
3
Other Long-Term Assets
0
4
7
2
0
0
0
0
0
0
Total Assets
4
N/A
33
+817%
38
+15%
30
-23%
37
+24%
18
-50%
13
-29%
50
+283%
27
-47%
8
-70%
Liabilities
Accounts Payable
1
0
2
3
4
3
3
4
1
1
Accrued Liabilities
13
9
6
4
3
5
4
7
4
4
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
1
0
0
0
0
0
0
0
0
Total Current Liabilities
14
10
8
7
7
8
8
10
5
5
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Liabilities
5
0
0
5
32
7
2
2
0
0
Total Liabilities
19
N/A
10
-46%
8
-23%
12
+45%
39
+236%
15
-63%
10
-34%
12
+26%
5
-56%
5
+3%
Equity
Common Stock
0
77
0
0
1
1
0
0
0
0
Retained Earnings
177
54
101
124
179
177
190
214
232
252
Additional Paid In Capital
0
0
131
142
176
180
193
253
254
255
Other Equity
161
0
0
0
0
0
0
0
0
0
Total Equity
16
N/A
23
N/A
30
+32%
18
-41%
3
N/A
4
N/A
4
-7%
38
+965%
22
-43%
3
-88%
Total Liabilities & Equity
4
N/A
33
+817%
38
+15%
30
-23%
37
+24%
18
-50%
13
-29%
50
+283%
27
-47%
8
-70%
Shares Outstanding
Common Shares Outstanding
1
1
1
2
4
4
5
9
10
10

See Also

Discover More